Newborn Screening Market By Product Type (Instruments, Reagents & Consumables, Others), By Test Type (Metabolic Disorders Screening, Endocrine Disorders Screening, Genetic Disorders Screening, Hemoglobinopathies Screening, Hearing Screening, Other Disorders Screening), By Technology (Tandem Mass Spectrometry (TMS), Polymerase Chain Reaction (PCR), Enzyme-linked Immunosorbent Assay (ELISA), DNA Sequencing, Immunoassay), By Screening Method (Blood Spot Screening, Urine Screening, Saliva Screening, Sweat Testing, Others), By End-User (Hospitals & Clinics, Laboratories, Research Institutes, Public Health Organizations). Global Market Size, Segmental analysis, Regional Overview, Company shares analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Newborn Screening Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Precision medicine offers targeted, efficient newborn screening tailored to individuals.

3.2.2. Technological advancements improve screening accuracy and detection capabilities.

3.2.3. Early diagnosis reduces long-term health complications and treatment costs.

3.3. Key industry pitfalls & challenges

3.3.1. High costs of advanced technologies limit adoption in low-income regions.

3.3.2. Insufficient infrastructure in developing countries hampers implementation of programs.

3.3.3. Ethical concerns around genetic data privacy affect screening adoption.

3.4. Market Opportunities

3.4.1. Telemedicine expands newborn screening access in rural and underserved areas.

3.4.2. Expanding newborn screening programs in emerging economies offers growth potential.

3.4.3. AI-driven technology enhances the efficiency and accuracy of newborn screening.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Newborn Screening Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Instruments

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Reagents & Consumables

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Others

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Newborn Screening Market, Test Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Test Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Metabolic Disorders Screening

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Endocrine Disorders Screening

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Genetic Disorders Screening

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Hemoglobinopathies Screening

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Hearing Screening

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Others

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Newborn Screening Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Tandem Mass Spectrometry (TMS)

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Polymerase Chain Reaction (PCR)

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Enzyme-linked immunosorbent Assay (ELISA)

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. DNA Sequencing

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Immunoassay

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Newborn Screening Market, Screening Method Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Screening Method, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Blood Spot Screening

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Urine Screening

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Saliva Screening

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Sweat Testing

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Others

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Newborn Screening Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals & Clinics

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Laboratories

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Research Institutes

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Public Health Organizations

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Newborn Screening Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Product Type, 2025-2035

9.2.3. North America Market Revenue, By Test Type, 2025-2035

9.2.4. North America Market Revenue, By Technology, 2025-2035

9.2.5. North America Market Revenue, By Screening Method, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Test Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.4. U.S. Market Revenue, By Screening Method, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Product Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Test Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Technology, 2025-2035

9.2.8.4. Canada Market Revenue, By Screening Method, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Product Type, 2025-2035

9.3.3. Europe Market Revenue, By Test Type, 2025-2035

9.3.4. Europe Market Revenue, By Technology, 2025-2035

9.3.5. Europe Market Revenue, By Screening Method, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Product Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Test Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Technology, 2025-2035

9.3.7.4. Germany Market Revenue, By Screening Method, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Product Type, 2025-2035

9.3.8.2. France Market Revenue, By Test Type, 2025-2035

9.3.8.3. France Market Revenue, By Technology, 2025-2035

9.3.8.4. France Market Revenue, By Screening Method, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Product Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Test Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.4. U.K. Market Revenue, By Screening Method, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Product Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Test Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Technology, 2025-2035

9.3.10.4. Italy Market Revenue, By Screening Method, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Product Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Test Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Technology, 2025-2035

9.3.11.4. Spain Market Revenue, By Screening Method, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Test Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Screening Method, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Screening Method, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Product Type, 2025-2035

9.4.7.2. China Market Revenue, By Test Type, 2025-2035

9.4.7.3. China Market Revenue, By Technology, 2025-2035

9.4.7.4. China Market Revenue, By Screening Method, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Product Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Test Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Technology, 2025-2035

9.4.8.4. Japan Market Revenue, By Screening Method, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Product Type, 2025-2035

9.4.9.2. India Market Revenue, By Test Type, 2025-2035

9.4.9.3. India Market Revenue, By Technology, 2025-2035

9.4.9.4. India Market Revenue, By Screening Method, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Product Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Test Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Technology, 2025-2035

9.4.10.4. Australia Market Revenue, By Screening Method, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Product Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Test Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.4. South Korea Market Revenue, By Screening Method, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Product Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Test Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.4. Singapore Market Revenue, By Screening Method, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Screening Method, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Product Type, 2025-2035

9.5.3. Latin America Market Revenue, By Test Type, 2025-2035

9.5.4. Latin America Market Revenue, By Technology, 2025-2035

9.5.5. Latin America Market Revenue, By Screening Method, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Test Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.4. Brazil Market Revenue, By Screening Method, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Test Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.4. Argentina Market Revenue, By Screening Method, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Test Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.4. Mexico Market Revenue, By Screening Method, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Test Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Screening Method, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Product Type, 2025-2035

9.6.3. MEA Market Revenue, By Test Type, 2025-2035

9.6.4. MEA Market Revenue, By Technology, 2025-2035

9.6.5. MEA Market Revenue, By Screening Method, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Product Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Test Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Screening Method, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Product Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Test Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.4. South Africa Market Revenue, By Screening Method, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Test Type, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Screening Method, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. PerkinElmer, Inc.

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Bio-Rad Laboratories, Inc

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Natus Medical Incorporated

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Abbott Laboratories

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Agilent Technologies, Inc.

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Thermo Fisher Scientific Inc.

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Medtronic PLC

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Hamilton Company

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. LabCorp

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Tecan Group Ltd.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. F. Hoffmann-La Roche AG

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Quest Diagnostics Incorporated

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. MSD Animal Health

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Sonic Healthcare

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Sysmex Corporation

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis